Skip to main content
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
21.11
+0.11 (0.52%)
At close: Apr 28, 2026, 4:00 PM EDT
21.50
+0.39 (1.85%)
After-hours: Apr 28, 2026, 6:39 PM EDT

Syndax Pharmaceuticals Revenue

In the year 2025, Syndax Pharmaceuticals had annual revenue of $172.35M with 627.84% growth. Syndax Pharmaceuticals had revenue of $68.73M in the quarter ending December 31, 2025, with 794.90% growth.

Revenue (ttm)
$172.35M
Revenue Growth
+627.84%
P/S Ratio
10.80
Revenue / Employee
$578,362
Employees
298
Market Cap
1.86B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025172.35M148.67M627.84%
Dec 31, 202423.68M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021139.71M138.19M9,109.56%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Galapagos NV 1.31B
Harmony Biosciences Holdings 868.45M
Vericel 276.26M
Stoke Therapeutics 184.42M
Recursion Pharmaceuticals 74.68M
Mesoblast 65.38M
Taysha Gene Therapies 9.77M
Inhibrx Biosciences 1.30M
Revenue Rankings

SNDX News

More News